Connection

Robert Notari to Hydrogen-Ion Concentration

Back to Details
This is a "connection" page, showing publications Robert Notari has written about Hydrogen-Ion Concentration.
Robert Notari
Connection Strength
0.365
Hydrogen-Ion Concentration
  1. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions. J Pharm Sci. 1995 May; 84(5):534-8.
    View in: PubMed
    Score: 0.110
  2. Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions. J Pharm Sci. 1998 Dec; 87(12):1572-6.
    View in: PubMed
    Score: 0.035
  3. A kinetic oxymoron: concentration-dependent first-order rate constants for hydrolysis of ceftazidime. J Pharm Sci. 1998 Jan; 87(1):53-8.
    View in: PubMed
    Score: 0.033
  4. Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution. J Pharm Sci. 1994 Apr; 83(4):577-81.
    View in: PubMed
    Score: 0.025
  5. Potential improvement in shelf life using the prodrug approach. II. A systematic examination of kinetic requirements. Pharm Res. 1988 Oct; 5(10):634-8.
    View in: PubMed
    Score: 0.017
  6. Potential improvement in the shelf life of parenterals using the prodrug approach: bacampicillin and talampicillin hydrolysis kinetics and utilization time. Pharm Res. 1988 May; 5(5):288-96.
    View in: PubMed
    Score: 0.017
  7. Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure. Pharm Res. 1987 Apr; 4(2):98-103.
    View in: PubMed
    Score: 0.016
  8. CYCOLHEXIMIDE TRANSFORMATIONS. II. KINETICS AND STABILITY IN A PHARMACEUTICALLY USEFUL PH RANGE. J Pharm Sci. 1965 Feb; 54:209-15.
    View in: PubMed
    Score: 0.013
  9. Theory and practice of prodrug kinetics. Methods Enzymol. 1985; 112:309-23.
    View in: PubMed
    Score: 0.013
  10. Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine. J Pharm Sci. 1984 Jul; 73(7):896-902.
    View in: PubMed
    Score: 0.013
  11. Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine. J Pharm Sci. 1984 Jun; 73(6):728-32.
    View in: PubMed
    Score: 0.013
  12. Theoretical basis for the detection of general-base catalysis in the presence of predominating hydroxide catalysis. J Pharm Sci. 1984 Jun; 73(6):724-7.
    View in: PubMed
    Score: 0.013
  13. Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions. J Pharm Sci. 1975 Jul; 64(7):1148-57.
    View in: PubMed
    Score: 0.007
  14. Pharmacokinetics and molecular modification: implications in drug design and evaluation. J Pharm Sci. 1973 Jun; 62(6):865-81.
    View in: PubMed
    Score: 0.006
  15. Arabinosylcytosine stability in aqueous solutions: pH profile and shelflife predictions. J Pharm Sci. 1972 Aug; 61(8):1189-96.
    View in: PubMed
    Score: 0.006
  16. Hydroxamic acids. IV. Hydroxide effect in hydroxylaminolysis of ethyl acetate. J Pharm Sci. 1972 Feb; 61(2):244-8.
    View in: PubMed
    Score: 0.005
  17. Intermolecular and intramolecular catalysis in deamination of cytosine nucleosides. J Pharm Sci. 1970 Jan; 59(1):27-32.
    View in: PubMed
    Score: 0.005
  18. Catalysis of streptovitacin A dehydration: kinetics and mechanisms. J Pharm Sci. 1969 Oct; 58(10):1203-8.
    View in: PubMed
    Score: 0.005
  19. Hydroxamic acids. II. Kinetics and mechanisms of hydroxyaminolysis of succinimide. J Pharm Sci. 1969 Sep; 58(9):1064-8.
    View in: PubMed
    Score: 0.005
  20. A mechanism for the hydrolytic deamination of cytosine arabinoside in aqueous buffer. J Pharm Sci. 1967 Jul; 56(7):804-9.
    View in: PubMed
    Score: 0.004
  21. Kinetics of calcium carbonate neutralization. First-order case of the cube-root law. J Pharm Sci. 1965 Oct; 54(10):1500-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.